Dominion Energy Q1 Operating EPS Beats Guidance, But Wait Rating Intact
Read source articleWhat happened
Dominion Energy reported Q1 2026 operating earnings of $0.95 per share, above the implied quarterly run rate of its FY2026 guidance of $3.45–$3.69, but GAAP net income fell to $0.69 from $0.77 a year ago due to ongoing cost pressures. The results reflect steady regulated utility performance, but the investment thesis remains tethered to two unresolved binary events: first power from the Coastal Virginia Offshore Wind (CVOW) project, targeted for March 2026, and the Virginia SCC's decision on large-load queue standards expected by September 2026. The DeepValue Master Report maintains a WAIT rating with a $64 base-case value, citing the risk of additional unrecoverable CVOW charges after a $258 million disallowance in 2025 and high leverage at 6.07x net debt/EBITDA. Q1 operating beat does not alleviate the core concern: capital program execution and regulatory recovery are unproven at scale, and the stock's upside depends on converting Virginia's massive data-center queue into enforceable, financeable contracts. Until CVOW reaches first power without further cost overruns and the SCC mandates readiness deposits and minimum-demand terms, the reward-to-risk skew remains tilted toward negative headlines.
Implication
Investors should not extrapolate the Q1 operating beat into a full-year upgrade, as utility earnings follow seasonal patterns and the $0.95 per share was partly aided by lower O&M and favorable weather. The core risk—an additional CVOW cost write-off or a delay in first power—remains the dominant swing factor, with the 10-K explicitly flagging tariff and litigation risks that could push total project costs higher. The upcoming SCC rulings on queue standards and GS-5 implementation are equally critical; without enforceable commitments from data-center customers, Dominion risks building stranded assets. Given net debt/EBITDA above 6x and negative free cash flow, the balance sheet offers little buffer for adverse regulatory outcomes, limiting the stock's downside support. The attractive entry zone per the report is $58, offering a 9% downside from current levels near $63; patient investors should wait for either CVOW first-power confirmation or SCC queue-standard approval before adding exposure.
Thesis delta
The Q1 operating beat supports the base-case scenario but does not alter the investment thesis, which is contingent on CVOW execution and SCC queue-standard decisions. No material shift in the risk/reward calculus; the WAIT rating and $64 base case remain appropriate. The bull-case probability of 25% requires both CVOW first power and favorable SCC outcomes, neither of which is yet confirmed.
Confidence
medium